Future Ethos Fund
Pre-Seed Venture Fund

Future Ethos Fund is a pre-seed venture fund investing exclusively in early-stage companies developing novel therapeutics, vaccines, and diagnostics in the infectious disease space.

We back scientific founders at the earliest stage, before most investors are paying attention, with a focus on companies that are building on strong non-dilutive foundations from programs like CARB-X, BARDA, NIH, and others.

Apply to Pitch
Our Thesis

Our thesis is simple.

  1. 01

    The sciencehas never been better.

  2. 02

    The policy tailwindis gaining traction.

  3. 03

    Pharma acquirersare rebuilding interest, creating exit pathways that didn't exist five years ago.

What We Bring

More than capital, to every company we back.

  • Deep infectious disease scientific expertise
  • A national life sciences network
  • Active relationships across the pharma BD and non-dilutive funding ecosystems
Who We Back

Scientific founders raising a pre-seed or seed round.

Focus Areas

  • Anti-infectives
  • Antimicrobials
  • Vaccines
  • Infectious disease diagnostics
  • Animal health

What We Look For

  • Strong early science
  • A clear mechanism of action
  • A vision for how your program reaches patients

We want to hear from you.

Apply to pitch Future Ethos at apply@futureethos.com or click the link below.

Apply to Pitch